markets

Magnificent Seven Stocks Stumble in 2025: One to Buy, One to Skip

Summarized from Yahoo

Most of the market's elite tech giants are lagging broader indexes this year. One stands out as a buy; another warrants caution.

The so-called Magnificent Seven — the cluster of mega-cap technology stocks that powered much of Wall Street's historic run in recent years — are showing significant cracks in 2025. According to a new analysis, five of the seven names are actually underperforming the broader market this year, a notable reversal for a group that had come to define momentum investing for retail and institutional traders alike.

The divergence matters because these stocks collectively represent an outsized share of major index funds, meaning their drag can quietly erode returns for millions of passive investors who may not realize their portfolios are concentrated in names that are no longer leading the charge. When the generals stop advancing, the army tends to stall.

Read more Why Big Tech's AI Spending Is Finally Winning Over Wall Street →

The analysis singles out two laggards that share similar underlying problems — likely a mix of valuation overextension, slowing growth narratives, or macro headwinds specific to their business lines. Yet despite those surface similarities, the case for one is far more compelling than the other, largely because of where its core business is headed strategically. One company's forward direction, whether in AI infrastructure, cloud expansion, or a pivot to new revenue streams, appears to justify near-term turbulence as a buying opportunity rather than a warning sign.

The other, by contrast, appears to lack the same clarity of purpose or near-term catalyst, making its underperformance harder to rationalize as temporary. In a market environment where capital is increasingly selective and the cost of waiting has risen alongside interest rates, investors need a credible story about when and how a recovery materializes — and that story seems thinner for the name the analysis recommends avoiding.

For long-term investors, the broader takeaway is that the Magnificent Seven was never a monolith, even during its peak dominance. Treating these companies as a single trade rather than a collection of distinct businesses with different growth trajectories is a mistake that 2025 is now making painfully visible. Continue reading at Yahoo.

Frequently Asked Questions

Q.How many Magnificent Seven stocks are underperforming the market in 2025?

According to the analysis, five of the seven Magnificent Seven stocks are underperforming the broader market so far in 2025, with only two outpacing the indexes.

Q.Why are most Magnificent Seven stocks lagging the market this year?

The analysis points to shared issues among the laggards, though it notes the problems are not identical across all names, with business direction playing a key role in distinguishing which companies can recover.

Q.What makes one Magnificent Seven stock a better buy than another despite similar problems?

The analysis argues that one company's strategic business direction makes its near-term underperformance easier to justify as a temporary setback, while the other lacks a clear catalyst or compelling forward narrative.

More in markets →